In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Industry experts ...
One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback